cancer - search results

Stephanie K. Watkins PhD from Loyola University Chicago shares her views on cancer immunotherapy therapy – the concept of using the immune system to fight and destroy cancer cells

Open Access Government (May 2018) "Thanks for the information. We have already tweeted and shared the article with our contacts. Thanks for this opportunity and feel free to contact me should you have future editions on the topic of cancer."   Marjorie Recorbet, The Cancer Drug Development Forum – CDDF

Dr Olga V Volpert’s work on sunlight-induced carcinogenesis at the MD Anderson Cancer Center is explored here, including why angiogenesis is critically important in skin cancer progression

The work of the National Cancer Institute (NCI), the federal government’s principal agency for cancer research and training in the United States, is profiled here by Open Access Government

Sumith A Kularatne, PhD, discusses his thoughts on the illusion of cancer and death

Managing Director of The Cancer Drug Development Forum, Prof. H. Zwierzina reveals his opinions on the current and future challenges of personalised cancer therapy, including the need for biomarkers.

Prime Minister Theresa May has announced a further £75m in funding for “earlier and faster” diagnosis and treatment of prostate cancer, which kills more than 10,000 men each year

Researchers at the National Institutes of Health (NIH) have used genomics to set apart squamous cancer cells (SCC’s) from other cancers. This could improve treatments for head and neck cancers.

Researchers have identified a new stem cell pathway that allows triple-negative breast cancer to thrive, with their findings potentially pointing the way towards more effective treatments

New research has found that the Zika virus could be an alternative for treatment of glioblastoma, the most common and aggressive kind of brain cancer in adults

Dr Miranda Fidler from the International Agency for Research on Cancer highlights the burden of cancer and the need for prevention, diagnosis, and care Cancer is a major cause of morbidity and mortality across all age groups in both developed and transitioning countries. Although substantial research on cancer in children...

CEO of Roy Castle Lung Cancer Foundation, Paula Chadwick, explains why it is now the time to finally prioritise lung health The events of Tuesday 21st November 2017 have the potential to change the lives of thousands of people in England. It was the day NHS England finally prioritised early...

All.Can shares their profound insights into the challenges concerning the need to improve the efficiency of cancer care, focusing on better outcomes for patients Healthcare budgets are under increasing pressure. We face an urgent question about how we can sustain high-quality healthcare. All.Can is an international multi-stakeholder initiative set up...

Cecilia Van Cauwenberghe, Vandana Iyer and Bhargav Rajan from Frost & Sullivan examine of how nanotechnology helps spot early stage cancer

Ivan Stamenkovic, professor of experimental pathology at the University of Lausanne underlines research taking place around cancer progression Cancer progression, meaning the evolution of localised tumour growth to an invasion of adjacent tissue and dissemination to distant organs is a complex process that is intimately related to interactions between tumour...

Experts from the University of Lausanne explore progress being made in the treatment of paediatric cancer in this fascinating ebook

After extended campaigns from charities and prominent figures, a lung cancer drug said to extend the life of sufferers has been made available on the NHS The nivolumab lung cancer drug is already available in Scotland for those with advanced lung cancer who are already undergoing chemotherapy. The immunotherapy treatment stimulates...

Progress in Targeted Therapy and Immunotherapy of Cancer Requires Rethinking of European Reimbursement Practices for Mutation Testing

Epigenetic changes play a critical role in the development of paediatric cancers. Ivan Stamenkovic, Professor of Pathology, explains

Science Information Officer Dr Catherine Pickworth outlines the work being carried out by Cancer Research UK to fight against pancreatic cancer